The Cooper Companies, Inc. $COO Stock Position Boosted by Jefferies Financial Group Inc.

Jefferies Financial Group Inc. grew its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 177.2% in the 4th quarter, HoldingsChannel.com reports. The firm owned 59,877 shares of the medical device company’s stock after purchasing an additional 38,277 shares during the period. Jefferies Financial Group Inc.’s holdings in Cooper Companies were worth $4,908,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in the business. New York Life Investment Management LLC boosted its position in shares of Cooper Companies by 0.6% during the 4th quarter. New York Life Investment Management LLC now owns 27,344 shares of the medical device company’s stock valued at $2,241,000 after purchasing an additional 158 shares in the last quarter. Allworth Financial LP boosted its position in shares of Cooper Companies by 14.1% during the 4th quarter. Allworth Financial LP now owns 1,355 shares of the medical device company’s stock valued at $111,000 after purchasing an additional 167 shares in the last quarter. Mesirow Financial Investment Management Inc. boosted its position in shares of Cooper Companies by 1.3% during the 3rd quarter. Mesirow Financial Investment Management Inc. now owns 14,017 shares of the medical device company’s stock valued at $961,000 after purchasing an additional 175 shares in the last quarter. Blue Trust Inc. boosted its holdings in shares of Cooper Companies by 13.9% in the fourth quarter. Blue Trust Inc. now owns 1,515 shares of the medical device company’s stock worth $124,000 after buying an additional 185 shares during the period. Finally, Norden Group LLC boosted its holdings in shares of Cooper Companies by 3.2% in the fourth quarter. Norden Group LLC now owns 6,634 shares of the medical device company’s stock worth $544,000 after buying an additional 205 shares during the period. Institutional investors own 24.39% of the company’s stock.

Analyst Ratings Changes

Several analysts recently commented on the stock. William Blair upgraded shares of Cooper Companies to a “strong-buy” rating in a report on Friday, January 30th. Wall Street Zen upgraded Cooper Companies from a “hold” rating to a “buy” rating in a research note on Saturday, February 28th. Rothschild & Co Redburn lowered shares of Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 price target on the stock. in a research report on Wednesday, March 4th. Citigroup dropped their price target on shares of Cooper Companies from $88.00 to $87.00 and set a “neutral” rating on the stock in a research report on Friday, March 6th. Finally, Needham & Company LLC lifted their price target on shares of Cooper Companies from $99.00 to $101.00 and gave the company a “buy” rating in a research report on Friday, March 6th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $90.79.

Cooper Companies Stock Performance

Shares of Cooper Companies stock opened at $62.55 on Tuesday. The firm has a market capitalization of $12.20 billion, a PE ratio of 30.97, a price-to-earnings-growth ratio of 1.61 and a beta of 0.89. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.34 and a quick ratio of 0.79. The company’s fifty day moving average price is $66.74 and its two-hundred day moving average price is $75.13. The Cooper Companies, Inc. has a 52-week low of $58.89 and a 52-week high of $89.83.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, March 5th. The medical device company reported $1.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.03 by $0.07. Cooper Companies had a net margin of 9.67% and a return on equity of 10.34%. The firm had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.02 billion. During the same quarter in the previous year, the firm posted $0.92 EPS. The business’s revenue for the quarter was up 6.2% on a year-over-year basis. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. On average, analysts expect that The Cooper Companies, Inc. will post 4.62 EPS for the current year.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.